Amanda Seegobin
Nurse Practitioner · Daytona Beach, FLNPI 1720539703
Payments from drug & device makers
Across 165 payments — averaging $22.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$360
- Vanda Pharmaceuticals Inc.$343
- Lilly USA, LLC$277
- UCB, Inc.$184
- Argenx US, Inc.$175
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,762100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $1,133 |
| Pfizer | 21 | $360 |
| Vanda Pharmaceuticals Inc. | 11 | $343 |
| Lilly USA, LLC | 12 | $277 |
| UCB, Inc. | 9 | $184 |
| Argenx US, Inc. | 9 | $175 |
| SK Life Science, Inc. | 4 | $125 |
| Jazz Pharmaceuticals Inc. | 6 | $124 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| Amneal Pharmaceuticals LLC | 5 | $99 |
| EMD Serono, Inc. | 3 | $69 |
| Acadia Pharmaceuticals Inc | 3 | $57 |
| Sanofi | 2 | $54 |
| Eisai Inc. | 3 | $52 |
| MDD US Operations, LLC | 3 | $52 |
| United Therapeutics Corporation | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Grifols USA, LLC | 2 | $40 |
| Neurocrine Biosciences, Inc. | 1 | $34 |
| Lundbeck LLC | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Microtransponder, Inc. | 1 | $23 |
| Globus Medical | 1 | $22 |
| Acorda Therapeutics, Inc | 1 | $21 |
| Catalyst Pharmaceuticals, Inc. | 1 | $20 |
| Novartis | 1 | $19 |
| Averitas Pharma Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Evoke Pharma, Inc. | 1 | $13 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,762 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 20 | $293 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Daytona Beach
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.